Luminex Multiplex Assays Market Projected to Reach USD 3.89 Billion by 2033, Driven by Rising Demand for High-Throughput Biomarker Profiling and Standardized Multiplex Testing Workflows: Verified Market Research

Increasing adoption of multiplexing technologies across clinical diagnostics, pharmaceutical and biotech research, academic research, and CRO environments is accelerating the evolution of workflow-driven biomarker testing and panel-based assay strategies. LEWES, Del., May 18, 2026...